GeneOne Life Science Inc (011000) — Long-term Investment Intensity
GeneOne Life Science Inc (011000) has a Long-term Investment Intensity of 0.6% as of December 2019. Long-term investments of ₩284.17 Million represent 0.6% of total assets of ₩51.15 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check GeneOne Life Science Inc liquid asset ratio to evaluate the company's liquid asset resilience ratio.
LT Investment Intensity
Long-term Investments
Total Assets
Country
GeneOne Life Science Inc Long-term Investment Intensity (2013–2019)
This chart shows how GeneOne Life Science Inc's Long-term Investment Intensity has evolved across 7 annual periods from 2013 to 2019. As of December 2019, the intensity stands at 0.6%, reflecting long-term investments of ₩284.17 Million against total assets of ₩51.15 Billion KRW. For the complete balance sheet picture, see 011000 asset base.
Annual Long-term Investment Intensity for GeneOne Life Science Inc (2013–2019)
The table below presents the year-by-year Long-term Investment Intensity for GeneOne Life Science Inc from 2013 to 2019, covering 7 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. Read 011000 current and long-term liabilities for a breakdown of total debt and financial obligations.
| Year | LT Investment Intensity | LT Investments (KRW) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2019 | 0.6% | ₩284.17 Million | ₩51.15 Billion | ▼ -0.1 pp |
| 2018 | 0.7% | ₩332.62 Million | ₩49.30 Billion | ▼ 0.0 pp |
| 2017 | 0.7% | ₩329.13 Million | ₩45.63 Billion | ▼ -0.2 pp |
| 2016 | 0.9% | ₩620.70 Million | ₩65.66 Billion | ▼ -0.3 pp |
| 2015 | 1.2% | ₩583.08 Million | ₩47.69 Billion | ▼ -0.7 pp |
| 2014 | 1.9% | ₩786.98 Million | ₩40.77 Billion | ▼ -1.0 pp |
| 2013 | 3.0% | ₩943.68 Million | ₩31.82 Billion | — |